» Download Public Reports
About 200 reports
- Company report
- October 2012
- 2 pages
... Significant innovations in our main investment areas of hearing systems, dialysis, orthopaedics, endoscopy, ventricular assist devices, heart valves, cardiac rhythm management, interventional cardiology ...
October 2012
... In a demanding environment, significant innovations in our main investment areas of hearing systems, dialysis, orthopaedics, endoscopy, ventricular assist devices, heart valves, cardiac rhythm management ...
September 2012
... Clinical cand that has emerged from the collaboration which the companies entered into in 2008, and will result in a 1 Million milestone payment to ablynx. We are very pleased to see our joint oncology ...
November 2012
... Pluristem to initiate a phase i/ii clinical trial in muscle injury product cand targets orthopedic and sports injuries, addresses a multi-billion dollar annual market haifa, israel ...
December 2012
... And surgical instruments specifically manufactured for each surgery. Surgeons are provided with kits that are uniquely tailored to each patient S joint anatomy, damage position and size of injury. Using ...
March 2013
... Guerbet is the only pharmaceutical group fully dedicated to medical imaging worldwide. As such it has a complete offering of contrast products for x-ray and mri and for interventional radiology, along ...
April 2013
... Yen astellas Our business model in global 4 urology transplantation oncology current gcl Neuroscience Dm complications & kidney diseases Immunology & infectious diseases third ...
October 2012
... Cam & computerized dentistry conference, i was concentrating on aligners, because the market is becoming very huge and a lot of doctors are willing to start using them. Technology is very advanced nowadays, so we ...
April 2013
... Advancement Requirement for multi-disciplinary working Evolution of vascular surgery as a monospeciality Provision of contemporary emergency services vascular surgery and contemporary ...
» Purchase Premium Reports
(From $ 125 - $ 3 995)
About 200 reports
- $ 3 995
- Industry report
- April 2013
- by Global Data
EpiCast Report: Idiopathic Pulmonary Fibrosis - Epidemiology Forecast to 2022 Summary Idiopathic pulmonary fibrosis (IPF) is a chronic, fibrosing interstitial pneumonia of unknown cause that occurs primarily ...
April 2013
$ 898
This trend is driving value growth of eye care as minor ailments, such as dry eye, are associated with age. The greater availability following the deregulation of pharmacy retailing also ensured growth ...
April 2013
$ 898
Before May, when consumers had to pay for only 25% of the retail price, the category was growing by nearly 3%; after May, when consumers had to pay for 100% of the retail price, value sales saw a significant ...
April 2013
$ 898
This was mainly due to rising pollution levels, the ageing population and the increasing popularity of wearing contact lenses. In addition, many people are working longer hours, often in front of compute ...
April 2013
$ 599
Euromonitor International's Industrial reports provide a 360 degree view of an market . The Industrial industry report offers a comprehensive guide to the size and shape of the Hospitals, Medical and Dental ...
March 2013
$ 300
This report is systematically updated by our analysts for each new purchase. This is to ensure that you get the latest information available on the company. The report will be updated and sent to you in ...
March 2013
$ 300
Summary CapRegen Limited (CapRegen), formerly known as Capregen Plc, is a UK based company, which was involved in the business of making investments in anti-ageing and regenerative medicine markets. CapRegen ...